deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06560307

Study of Enhanced Programming Stimulation with the Enterra® Therapy System (EXPEDITE)

Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation

Sponsor: Enterra Medical, Inc.

Conditions Gastroparesis Gastroparesis Due to Diabetes Mellitus Gastroparesis Nondiabetic
Interventions Enterra Therapy System
Updated 3 times since 2024 Last updated: Nov 13, 2024 Started: Jul 25, 2024 Primary completion: Oct 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gastroparesis and Gastroparesis Due to Diabetes Mellitus and is currently actively recruiting participants. Enterra Medical, Inc. leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotRecruiting~Sep 2025 – present · 11 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Dec 2024 — Sep 2025 [monthly]

    Recruiting NA

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

    First recorded

Jul 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Enterra Medical, Inc.
Data source: Enterra Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations